iconstar paper   Hepatitis C Articles (HCV)  
Back grey arrow rt.gif
 
 
SOF/velpatasvir DDIs
 
 
  FDA approved this new pangenotypic HCV treatment June 28 2016
 
Drug-Drug Interaction Studies Between Hepatitis C Virus Antivirals Sofosbuvir and Velpatasvir (GS-5816) and HIV Antiretoviral Therapies - (12/08/15)
 
EASL: Drug-Drug Interaction Profile of Sofosbuvir/Velpatasvir Fixed-Dose Combination - (04/21/16)
 
Sofosbuvir/Valpatasvir FDA Product Label - (06/29/16)
 
  
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org